March 14, 2022, KevinMD
Tackling Trial Delays, Social Inflation, and Skeptical Jurors in a Pandemic World
Marco Spadacenta, Senior Vice President of Claims for The Doctors Company, discusses the changing face of trials and jurors and suggests what can be done in light of these changes to successfully defend physicians in medical malpractice cases.
Search
December 01, 2022, Healthcare Risk Management
Remember the Basics of Good Documentation
Richard Cahill, JD, Vice President and Associate General Counsel, The Doctors Company, provides suggestions for executing good documentation practices to accurately record patient encounters.
Fitch Ratings Affirms ‘A’ Ratings, ‘Stable’ Outlook for The Doctors Company
Fitch Ratings has affirmed its “A” (Strong) Insurer Financial Strength ratings for The Doctors Company, the nation’s largest physician-owned medical malpractice insurer and part of TDC Group. The outlook of these ratings is “Stable.”
Mar 07, 2023
In Memoriam: Donald J. Palmisano, MD, JD, FACS
It is with great sadness that we report the passing of long-time Board Member Donald J. Palmisano, MD, JD, FACS.
From
The Doctor’s Advocate
January 31, 2022, Medscape
Medscape Ob/Gyn Malpractice Report 2021
Peter Kolbert, JD, Senior Vice President of Claim and Litigation Services for Healthcare Risk Advisors, part of TDC Group, notes why ob/gyn carries significant financial exposure with lawsuits.
September 01, 2023, Part B News
Head Off Problem Patients With Signed Agreements, Legal Review: Expert
Richard F. Cahill, Esq., Vice President and Associate General Counsel, The Doctors Company, part of TDC Group, discusses the rights and responsibilities of practice managers who wish to remove or stop admitting troublesome patients.
Aug 27, 2024
Industry and Company News
Announcements in the third quarter 2024 include recognition for our Claims team, a new article by Bob White featured in Fortune, and affirmation of our commitment to health workforce well-being.
From
The Doctor’s Advocate
Jun 18, 2024
Industry and Company News
The second quarter 2024 issue includes announcements about a member dividend and the appointment of our new chief operating officer.
From
The Doctor’s Advocate
Shoulder Dystocia Documentation: Implementing a Protocol
Shoulder dystocia claims have traditionally been among the most problematic to defend.
Dec 01, 2022
Industry and Company News
Announcements in the fourth quarter of 2022 include our AM Best ‘A’ (Excellent) Financial Rating, new Leading Voices in Healthcare resources, and a new article exploring technology-enabled healthcare.
From
The Doctor’s Advocate